PRAME expression and promoter hypomethylation in epithelial ovarian cancer

PRAME is a cancer-testis antigen (CTA) and potential immuno-therapeutic target, but has not been well-studied in epithelial ovarian cancer (EOC) or its high grade serous (HGSC) subtype. Compared to normal ovary, PRAME expression was significantly increased most EOC, regardless of stage and grade. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wa, Barger, Carter J., Eng, Kevin H., Klinkebiel, David, Link, Petra A., Omilian, Angela, Bshara, Wiam, Odunsi, Kunle, Karpf, Adam R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216727/
https://www.ncbi.nlm.nih.gov/pubmed/27322684
http://dx.doi.org/10.18632/oncotarget.9977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216727/
https://www.ncbi.nlm.nih.gov/pubmed/27322684
http://dx.doi.org/10.18632/oncotarget.9977

Ejemplares similares